Comparative peptidomics analysis of neural adaptations in rats repeatedly exposed to amphetamine

Journal of Neurochemistry

Volumn 123, Issue 2, 2012, Pages 276-287

  Romanova, Elena V ^a   Lee, Ji Eun ^a,c   Kelleher, Neil L ^b   Sweedler, Jonathan V ^a   Gulley, Joshua M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

addiction; mass spectrometry; neurochemical adaptation; peptidomics; principal component analysis; proteo mics

Indexed keywords

AMPHETAMINE; BIOLOGICAL MARKER; HISTISDINE TRIAD NUCLEOTIDE BINDING PROTEIN 1; NEUROMODULIN; NEUROPEPTIDE; SYNAPTOGYRIN 1; THYMOSIN BETA10; THYMOSIN BETA4; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ABUSE; ENERGY METABOLISM; FUNCTIONAL PROTEOMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LONG TERM EXPOSURE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROCHEMISTRY; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PEPTIDOMICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; SENSITIZATION; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

ADAPTATION, PHYSIOLOGICAL; AMPHETAMINE; ANIMALS; BRAIN CHEMISTRY; MALE; NEURONS; PEPTIDOMIMETICS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; TANDEM MASS SPECTROMETRY;

RATTUS; RODENTIA;

EID: 84867064628     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07912.x     Document Type: Article

References (79)

1. Abul-Husn N. S., and, Devi L. A., (2006) Neuroproteomics of the synapse and drug addiction. J. Pharmacol. Exp. Ther. 318, 461-468.
2. Albertson D. N., Schmidt C. J., Kapatos G., and, Bannon M. J., (2006) Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse. Neuropsychopharmacology 31, 2304-2312.
3. Barbier E., Zapata A., Oh E., Liu Q., Zhu F., Undie A., Shippenberg T., and, Wang J. B., (2007) Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice. Neuropsychopharmacology 32, 1774-1782.
4. Bartlett E., Hallin A., Chapman B., and, Angrist B., (1997) Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability? Neuropsychopharmacology 16, 77-82.
5. Belmont L. D., and, Mitchison T. J., (1996) Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell 84, 623-631.
6. Bodnar W. M., Blackburn R. K., Krise J. M., and, Moseley M. A., (2003) Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage. J. Am. Soc. Mass Spectrom. 14, 971-979.
7. Boileau I., Dagher A., Leyton M., Gunn R. N., Baker G. B., Diksic M., and, Benkelfat C., (2006) Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Arch. Gen. Psychiatry 63, 1386-1395.
8. Boyne M. T., Garcia B. A., Li M., Zamdborg L., Wenger C. D., Babai S., and, Kelleher N. L., (2009) Tandem mass spectrometry with ultrahigh mass accuracy clarifies peptide identification by database retrieval. J. Proteome Res. 8, 374-379.
9. Brereton R., (2009) Chemometrics for Pattern Recognition. John Wiley & Sons, Ltd, Chichester, West Sussex, UK.
10. Burrows K. B., Gudelsky G., and, Yamamoto B. K., (2000) Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. Eur. J. Pharmacol. 398, 11-18.
11. Chang L., Alicata D., Ernst T., and, Volkow N., (2007) Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102, 16-32.
12. Chen B. T., Hopf F. W., and, Bonci A., (2009) Synaptic plasticity in the mesolimbic system. Ann. N. Y. Acad. Sci. 1187, 129-139.
13. Cheng M.-C., and, Chen C.-H., (2007) Identification of rare mutations of synaptogyrin 1 gene in patients with schizophrenia. J. Psychiatr. Res. 41, 1027-1031.
14. Choi S. Y., Kim D. K., Eun B., Kim K., Sun W., and, Kim H., (2006) Anti-apoptotic function of thymosin-beta in developing chick spinal motoneurons. Biochem. Biophys. Res. Commun. 346, 872-878.
15. Cunha-Oliveira T., Rego A. C., Cardoso S. M., Borges F., Swerdlow R. H., Macedo T., and, de Oliveira C. R., (2006) Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine. Brain Res. 1089, 44-54.
16. Darde V. M., de la Cuesta F., Dones F. G., Alvarez-Llamas G., Barderas M. G., and, Vivanco F., (2010) Analysis of the plasma proteome associated with acute coronary syndrome: does a permanent protein signature exist in the plasma of ACS patients? J. Proteome Res. 9, 4420-4432.
17. Dudoit S., and, Shaffer J. P., (2003) Multiple hypothesis testing in microarray experiments. Stat. Sci. 18, 71-103.
18. Erhardt J. A., Legos J. J., Johanson R. A., Slemmon J. R., and, Wang X., (2000) Expression of PEP-19 inhibits apoptosis in PC12 cells. NeuroReport, 11, 3719-3723.
19. Faure J. J., Hattingh S. M., Stein D. J., and, Daniels W. M., (2009) Proteomic analysis reveals differentially expressed proteins in the rat frontal cortex after methamphetamine treatment. Metab. Brain Dis. 24, 685-700.
20. Fenn J. B., Mann M., Meng C. K., Wong S. F., and, Whitehouse C. M., (1989) Electrospray ionization for mass spectrometry of large biomolecules. Science 246, 64-71.
21. Fountoulakis M., Hardmeier R., Hoger H., and, Lubec G., (2001) Postmortem changes in the level of brain proteins. Exp. Neurol. 167, 86-94.
22. Fricker L. D., Lim J., Pan H., and, Che F. Y., (2006) Peptidomics: identification and quantification of endogenous peptides in neuroendocrine tissues. Mass Spectrom. Rev. 25, 327-344.
23. Gnegy M. E., Hong P., and, Ferrell S. T., (1993) Phosphorylation of neuromodulin in rat striatum after acute and repeated, intermittent amphetamine. Mol. Brain Res. 20, 289-298.
24. Guang W., Wang H., Su T., Weinstein I. B., and, Wang J. B., (2004) Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia. Mol. Pharmacol. 66, 1285-1292.
25. Hanrieder J., Wicher G., Bergquist J., Andersson M., and, Fex-Svenningsen A., (2011) MALDI mass spectrometry based molecular phenotyping of CNS glial cells for prediction in mammalian brain tissue. Anal. Bioanal. Chem. 401, 135-147.
26. Heinz A., and, Schlagenhauf F., (2010) Dopaminergic dysfunction in schizophrenia: salience attribution revisited. Schizophr. Bull. 36, 472-485.
27. Hillenkamp F., and, Karas M., (2007) The MALDI process and method, in A Practical Guide to Instrumentation, Methods and Applications (, Hillenkamp F., and, Peter-Katalinia J., eds), pp. 1-28. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany.
28. Himi T., Okazaki T., Wang H., McNeill T. H., and, Mori N., (1994) Differential localization of SCG10 and p19/stathmin messenger RNAs in adult rat brain indicates distinct roles for these growth-associated proteins. Neuroscience 60, 907-926.
29. Hiroshi U., Manabu T., Masafumi K., and, Shigetoshi K., (2002) Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ann. N. Y. Acad. Sci. 965, 55-67.
30. Huff T., Müller C. S. G., Otto A. M., Netzker R., and, Hannappel E., (2001) [beta]-Thymosins, small acidic peptides with multiple functions. Int. J. Biochem. Cell Biol. 33, 205-220.
31. Jackson K. J., Chen Q., Chen J., Aggen S. H., Kendler K. S., and, Chen X., (2010) Association of the histidine-triad nucleotide-binding protein-1 (HINT1) gene variants with nicotine dependence. Pharmacogenomics J. 11, 251-257.
32. Kalivas P. W., and, Volkow N. D., (2005) The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 162, 1403-1413.
33. Kalivas P. W., Pierce R. C., Cornish J., and, Sorg B. A., (1998) A role for sensitization in craving and relapse in cocaine addiction. J. Psychopharmacol. 12, 49-53.
34. Kalivas P. W., Volkow N., and, Seamans J., (2005) Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 45, 647-650.
35. Kolb B., (1984) Functions of the frontal cortex of the rat: a comparative review. Brain Res. Rev. 8, 65-98.
36. Kruskal W. H., and, Wallis W. A., (1952) Use of ranks in one-criterion variance analysis. J. Am. Stat. Assoc. 47, 588-621.
37. Lee S. H., Son M. J., Oh S. H., Rho S. B., Park K., Kim Y. J., Park M. S., and, Lee J. H., (2005) Thymosin {beta}(10) inhibits angiogenesis and tumor growth by interfering with Ras function. Cancer Res. 65, 137-148.
38. Lee J. E., Atkins Jr N., Hatcher N. G., Zamdborg L., Gillette M. U., Sweedler J. V., and, Kelleher N. L., (2010) Endogenous peptide discovery of the rat circadian clock: a focused study of the suprachiasmatic nucleus by ultrahigh performance tandem mass spectrometry. Mol. Cell. Proteomics 9, 285-297.
39. Lehrmann E., and, Freed W. J., (2008) Transcriptional correlates of human substance use. Ann. N. Y. Acad. Sci. 1139, 34-42.
40. Lehrmann E., Oyler J., Vawter M. P., Hyde T. M., Kolachana B., Kleinman J. E., Huestis M. A., Becker K. G., and, Freed W. J., (2003) Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J. 3, 27-40.
41. Lenka N., Vijayasarathy C., Mullick J., Avadhani N. G., and, Kivie M., (1998) Structural organization and transcription regulation of nuclear genes encoding the mammalian cytochrome c oxidase complex. Prog. Nucleic Acid Res. Mol. Biol. 61, 309-344.
42. Li L., and, Sweedler J. V., (2008) Peptides in the brain: mass spectrometry-based measurement approaches and challenges. Annu. Rev. Anal. Chem. (Palo Alto Calif) 1, 451-483.
43. Lindvall O., Björklund A., and, Divac I., (1978) Organization of catecholamine neurons projecting to the frontal cortex in the rat. Brain Res. 142, 1-24.
44. Marshall J. F., Belcher A. M., Feinstein E. M., and, O'Dell S. J., (2007) Methamphetamine-induced neural and cognitive changes in rodents. Addiction 102, 61-69.
45. Melo P., Moreno V. Z., Vázquez S. P., Pinazo-Durán M. D., and, Tavares M. A., (2006) Myelination changes in the rat optic nerve after prenatal exposure to methamphetamine. Brain Res. 1106, 21-29.
46. Molle D., Jardin J., Piot M., Pasco M., Leonil J., and, Gagnaire V., (2009) Comparison of electrospray and matrix-assisted laser desorption ionization on the same hybrid quadrupole time-of-flight tandem mass spectrometer: application to bidimensional liquid chromatography of proteins from bovine milk fraction. J. Chromatogr. 1216, 2424-2432.
47. Morris D. C., Chopp M., Zhang L., and, Zhang Z. G., (2010) Thymosin beta4: a candidate for treatment of stroke? Ann. N. Y. Acad. Sci. 1194, 112-117.
48. Paxinos G., and, Watson C., (2007) The Rat Brain in Stereotaxic Coordinates. New York: Academic Press.
49. Philp D., and, Kleinman H. K., (2010) Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide. Ann. N. Y. Acad. Sci. 1194, 81-86.
50. Putkey J. A., Kleerekoper Q., Gaertner T. R., and, Waxham M. N., (2003) A new role for IQ motif proteins in regulating calmodulin function. J. Biol. Chem. 278, 49667-49670.
51. Rajalahti T., Kroksveen A. C., Arneberg R., Berven F. S., Vedeler C. A., Myhr K. M., and, Kvalheim O. M., (2010) A multivariate approach to reveal biomarker signatures for disease classification: application to mass spectral profiles of cerebrospinal fluid from patients with multiple sclerosis. J. Proteome Res. 9, 3608-3620.
52. Rezin G., Amboni G., Zugno A., Quevedo J., and, Streck E., (2009) Mitochondrial dysfunction and psychiatric disorders. Neurochem. Res. 34, 1021-1029.
53. Robinson T. E., and, Berridge K. C., (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 18, 247-291.
54. Robinson T. E., and, Berridge K. C., (2000) The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95, S91-S117.
55. Robinson T. E., and, Kolb B., (1997) Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J. Neurosci. 17, 8491-8497.
56. Robinson T. E., Becker J. B., Moore C. J., Castaneda E., and, Mittleman G., (1985) Enduring enhancement in frontal cortex dopamine utilization in an animal model of amphetamine psychosis. Brain Res. 343, 374-377.
57. Romanova E. V., Roth M. J., Rubakhin S. S., Jakubowski J. A., Kelley W. P., Kirk M. D., Kelleher N. L., and, Sweedler J. V., (2006) Identification and characterization of homologues of vertebrate beta-thymosin in the marine mollusk Aplysia californica. J. Mass Spectrom. 41, 1030-1040.
58. Romanova E. V., Rubakhin S. S., and, Sweedler J. V., (2008) One-step sampling, extraction, and storage protocol for peptidomics using dihydroxybenzoic acid. Anal. Chem. 80, 3379-3386.
59. Romanova E. V., Hatcher N. G., Rubakhin S. S., and, Sweedler J. V., (2009) Characterizing intercellular signaling peptides in drug addiction. Neuropharmacology 56, 196-204.
60. Romanova E. V., Lee J. E., Kelleher N. L., Sweedler J. V., and, Gulley J. M., (2010) Mass spectrometry screening reveals peptides modulated differentially in the medial prefrontal cortex of rats with disparate initial sensitivity to cocaine. AAPS J. 12, 443-454.
61. Rossbach U., Nilsson A., Falth M., Kultima K., Zhou Q., Hallberg M., Gordh T., Andren P. E., and, Nyberg F., (2009) A quantitative peptidomic analysis of peptides related to the endogenous opioid and tachykinin systems in nucleus accumbens of rats following naloxone-precipitated morphine withdrawal. J. Proteome Res. 8, 1091-1098.
62. Segal D. S., and, Schuckit M. A., (1983) Animal models of stimulant-induced psychosis, in Stimulants: Neurochemical, Behavioral, and Clinical Perspectives (, Creese I., ed.), pp. 131-167. Raven Press, New York.
63. Singer B. F., Tanabe L. M., Gorny G., Jake-Matthews C., Li Y., Kolb B., and, Vezina P., (2009) Amphetamine-induced changes in dendritic morphology in rat forebrain correspond to associative drug conditioning rather than nonassociative drug sensitization. Biol. Psychiatry 65, 835-840.
64. Slemmon J. R., Morgan J. I., Fullerton S. M., Danho W., Hilbush B. S., and, Wengenack T. M., (1996) Camstatins are peptide antagonists of calmodulin based upon a conserved structural motif in PEP-19, neurogranin, and neuromodulin. J. Biol. Chem. 271, 15911-15917.
65. Sobel A., (1991) Stathmin: a relay phosphoprotein for multiple signal transduction? Trends Biochem. Sci. 16, 301-305.
66. Stanis J. J., Marquez Avila H., White M. D., and, Gulley J. M., (2008) Dissociation between long-lasting behavioral sensitization to amphetamine and impulsive choice in rats performing a delay-discounting task. Psychopharmacology 199, 539-548.
67. Stapels M., and, Barofsky D., (2004) Complementary use of MALDI and ESI for the HPLC-MS/MS analysis of DNA-binding proteins. Anal. Chem. 76, 5423-5430.
68. Stephens M. A., (1974) EDF for goodness of fit and some comparisons. J. Am. Stat. Assoc. 69, 730-737.
69. Strakowski S. M., DelBello M. P., and, Adler C. M., (2001) Comparative efficacy and tolerability of drug treatments for bipolar disorder. CNS Drugs 15, 701-718.
70. Svensson M., Skold K., Nilsson A., Falth M., Svenningsson P., and, Andren P. E., (2007) Neuropeptidomics: expanding proteomics downwards. Biochem. Soc. Trans. 35, 588-593.
71. Toda S., Shen H. W., Peters J., Cagle S., and, Kalivas P. W., (2006) Cocaine increases actin cycling: effects in the reinstatement model of drug seeking. J. Neurosci. 26, 1579-1587.
72. Ujike H., and, Sato M., (2004) Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann. N. Y. Acad. Sci. 1025, 279-287.
73. Uys J. D., Grey A. C., Wiggins A., Schwacke J. H., Schey K. L., and, Kalivas P. W., (2010) Matrix-assisted laser desorption/ionization tissue profiling of secretoneurin in the nucleus accumbens shell from cocaine-sensitized rats. J. Mass Spectrom. 45, 97-103.
74. Wei H., Nolkrantz K., Parkin M. C., Chisolm C. N., O'Callaghan J. P., and, Kennedy R. T., (2006) Identification and quantification of neuropeptides in brain tissue by capillary liquid chromatography coupled off-line to MALDI-TOF and MALDI-TOF/TOF-MS. Anal. Chem. 78, 4342-4351.
75. Wilcoxon F., (1945) Individual comparisons by ranking methods. Biometrics 1, 80-83.
76. Yang H., Cheng X., Yao Q., Li J., and, Ju G., (2008a) The promotive effects of thymosin β4 on neuronal survival and neurite outgrowth by upregulating L1 expression. Neurochem. Res. 33, 2269-2280.
77. Yang M. H., Kim S., Jung M. S., et al,. (2008b) Proteomic analysis of methamphetamine-induced reinforcement processes within the mesolimbic dopamine system. Addict. Biol. 13, 287-294.
78. Yang H., Cui G. B., Jiao X. Y., Wang J., Ju G., and, You S. W., (2010) Thymosin-beta4 attenuates ethanol-induced neurotoxicity in cultured cerebral cortical astrocytes by inhibiting apoptosis. Cell. Mol. Neurobiol. 30, 149-160.
79. Zvonok N., Xu W., Williams J., Janero D. R., Krishnan S. C., and, Makriyannis A., (2010) Mass spectrometry-based GPCR proteomics: comprehensive characterization of the human cannabinoid 1 receptor. J. Proteome Res. 9, 1746-1753.